Butterfly Network announces preliminary findings from Pocus impact study

Butterfly Network (BFLY) announced preliminary findings from a seminal study conducted by Rutgers Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, demonstrating the impact of point-of-care ultrasound on patient outcomes and hospital efficiency. A late-breaking clinical trial presentation of the data was disseminated at the European Association of Cardiovascular Imaging’s EchoEuro-Imaging Conference in Berlin, Germany in December 2024. The study focused on using cardiopulmonary Pocus for patients admitted to the hospital with shortness of breath without an identifiable cause. It was designed as a prospective, head-to-head comparison of hospital physicians who utilized Butterfly iQ+ and/or iQ3 Pocus devices versus those who did not use Pocus. Results showed a significant reduction in both hospital length of stay and healthcare costs. Patients experienced an average LOS reduction of over four days. Lower-acuity patients saw their LOS reduced from 6.7 to 5.6 days. For higher-acuity patients, LOS was reduced from 39 to 16.7 days. These reductions also translated into substantial financial savings, with lower-acuity patients experiencing up to 50% cost reduction.